Across TCGA pan-cancer cohorts, MYL8P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MYL8P data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MYL8P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MYL8P expression acts as an unfavorable survival marker, although some lineages such as DLBC and CESC show a favorable association.
ACC, BLCA, and LUSC are the cancer types where MYL8P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.